Literature DB >> 18042135

Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor-null mutant (db/db) mice.

Douglas E Wright1, Megan S Johnson, M G Arnett, Susan E Smittkamp, Janelle M Ryals.   

Abstract

Much of our understanding of the effects of diabetes on the peripheral nervous system is derived from models induced by streptozotocin in which hyperglycemia is rapidly caused by pancreatic beta-cell destruction. Here, we have quantified sensory impairments over time in leptin receptor (lepr)-null mutant -/- mice, a type 2 model of diabetes in which the absence of leptin receptor signaling leads to obesity and chronic hyperglycemia by 4 weeks of age. To assess these mice as a model for peripheral neuropathy, we quantified the responsiveness of lepr -/- mice to mechanical, thermal, and chemogenic stimuli, as well as epidermal and dermal innervation of the hind paw. Compared with wild-type +/+ and heterozygous +/- mice, lepr -/- mice displayed reduced sensitivity to mechanical stimuli by 6 weeks of age, and however, responses to noxious heat were normal. Lepr -/- mice also devoted less activity to their injected paw during the second phase following formalin administration. However, epidermal and dermal innervation of lepr -/- mice was not different from that of lepr +/+ and +/- mice even after 10 weeks of hyperglycemia, suggesting that cutaneous innervation is resistant to chronic hyperglycemia in these mice. These results suggest that certain rodent nocifensive behaviors may be linked to the abundance of cutaneous innervation, while others are not. Finally, these results reveal that the lepr -/- mice may not be useful to study neuropathy associated with distal axonal degeneration but may be better suited for studies of hyperglycemia-induced sensory neuron dysfunction without distal nerve loss.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042135     DOI: 10.1111/j.1529-8027.2007.00144.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  22 in total

1.  Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

Authors:  L Wang; M Chopp; A Szalad; Z Liu; M Bolz; F M Alvarez; M Lu; L Zhang; Y Cui; R L Zhang; Z G Zhang
Journal:  Neuroscience       Date:  2011-07-27       Impact factor: 3.590

2.  Peripheral Leptin Signaling Mediates Formalin-Induced Nociception.

Authors:  Zhi-Jing Hu; Wei Han; Chang-Qing Cao; Qi-Liang Mao-Ying; Wen-Li Mi; Yan-Qing Wang
Journal:  Neurosci Bull       Date:  2017-12-05       Impact factor: 5.203

Review 3.  Mouse models of diabetic neuropathy.

Authors:  Phillipe D O'Brien; Stacey A Sakowski; Eva L Feldman
Journal:  ILAR J       Date:  2014

Review 4.  Diabetic painful and insensate neuropathy: pathogenesis and potential treatments.

Authors:  Irina G Obrosova
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

5.  Ectopic endometrium-derived leptin produces estrogen-dependent chronic pain in a rat model of endometriosis.

Authors:  P Alvarez; O Bogen; X Chen; L C Giudice; J D Levine
Journal:  Neuroscience       Date:  2013-11-14       Impact factor: 3.590

6.  Early loss of peptidergic intraepidermal nerve fibers in an STZ-induced mouse model of insensate diabetic neuropathy.

Authors:  Megan S Johnson; Janelle M Ryals; Douglas E Wright
Journal:  Pain       Date:  2008-08-30       Impact factor: 6.961

7.  Extracellular signal-regulated protein kinase activation in spinal cord contributes to pain hypersensitivity in a mouse model of type 2 diabetes.

Authors:  Xiang Xu; Hui Chen; Bing-Yu Ling; Lan Xu; Hong Cao; Yu-Qiu Zhang
Journal:  Neurosci Bull       Date:  2013-11-05       Impact factor: 5.203

Review 8.  Mouse forward genetics in the study of the peripheral nervous system and human peripheral neuropathy.

Authors:  Darlene S Douglas; Brian Popko
Journal:  Neurochem Res       Date:  2008-05-15       Impact factor: 3.996

9.  Spinal leptin contributes to the pathogenesis of neuropathic pain in rodents.

Authors:  Grewo Lim; Shuxing Wang; Yi Zhang; Yinghong Tian; Jianren Mao
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

10.  Nerve growth factor mediates mechanical allodynia in a mouse model of type 2 diabetes.

Authors:  Hsinlin T Cheng; Jacqueline R Dauch; John M Hayes; Yu Hong; Eva L Feldman
Journal:  J Neuropathol Exp Neurol       Date:  2009-11       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.